Kirk Nielsen

Vensana Capital thesis

Justin Klein is a co-founder and Managing Partner at Vensana Capital, a leading venture capital and growth equity firm dedicated to medtech innovation. Justin currently or previously served on the board of directors of Abrus Bio, Apella, Cartiva (acquired), ChromaCode, Cleerly, Curate BioSciences, CV Ingenuity (acquired), Epix Therapeutics (acquired), Evident Vascular, Intact Vascular (acquired), Luna Diabetes, Personal Genome Diagnostics (acquired), PhaseBio Pharmaceuticals (IPO), Relievant Medsystems (acquired), Senseonics (IPO), Topera (acquired), Ulthera (acquired), Ventaris Surgical, Vert

Sector and stage focus

• Series A: Consumer Health, Health IT, Health & Hospital Services
• Seed: Consumer Health, Health IT, Health & Hospital Services
• general: San Francisco Bay Area, Midwest

Is Kirk Nielsen a fit for your round?

Upload your pitch deck and see whether Kirk Nielsen appears in your top 20 matches.